Navigation Links
Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City
Date:5/21/2008

paradigms, and enhanced analysis of samples.

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (PBI) is a publicly traded company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and higher) to control bio-molecular interactions. PBI currently holds 13 US and 6 foreign patents covering multiple applications of PCT in the life sciences field, including such areas as genomic and proteomic sample preparation, pathogen inactivation, the control of enzymes, immunodiagnostics, and protein purification.

Forward Looking Statements

Statements contained in this press release regarding the Company's intentions, hopes, beliefs, expectations, or predictions of the future are "forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include the reported effectiveness of PCT to extract new proteins; the speed of sample preparation using PCT compared with current sample preparation methods; the importance of ProteoSolve-LRS and PCT in the reported identification of new proteins; the speed, cost, and quality advantages of ProteoSolve-LRS and PCT over other sample preparation methods; and the possibility that extraction of proteins by ProteoSolve-LRS and PCT may result in new therapeutic strategies, diagnostic paradigms, and enhanced analysis of samples. These statements are based upon the Company's current expectations, forecasts, and assumptions that are subject to risks, uncertainties, and other factors that could cause actual outcomes and results to differ materially from those indicated by these forward-looking statements. These risks, uncertainties, and other factors include, but are not limited to: unforeseen technological difficulties that the Company may encounter in the development of the PCT technology and the PCT Sample Prepa
'/>"/>

SOURCE Pressure BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Seven-Year Neck Pain Study Sheds Light on Best Care
2. MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule
3. Stereotaxis Market Leadership Reinforced in Core Curriculum and Symposium Presentations at Heart Rhythm 2008
4. BiPar Sciences Announces Clinical Data Presentations on Lead PARP Inhibitor, BSI-201, at 40th American Society of Clinical Oncology Annual Meeting
5. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting
6. Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents
7. Kosan Announces Data Presentations at ASCO 2008 Annual Meeting
8. Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology
9. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
10. Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
11. SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014  Decision Resources Group finds that, for ... Brazil and Mexico ... prescribe long-acting beta-agonist (LABA)- and long-acting muscarinic antagonist ... current severe cost/coverage constraints. Therefore, new brands of ... launch in these countries—which will considerably expand the ...
(Date:8/21/2014)... Germany , Aug. 21, 2014  IBM (NYSE: ... Elektronen-Synchrotron ( DESY ), a leading national research center ... management and storage of massive volumes of x-ray data. ... based on IBM software defined technology can handle more ... performance and help scientists worldwide gain faster insights into ...
(Date:8/21/2014)...  Seventy-one percent of Americans believe the abuse of strong ... health and safety issue in the United States ... by Repass & Partners, a Cincinnati ... severity of the prescription medication abuse problem and the need ... health situation facing our country," Rex Repass , CEO ...
Breaking Medicine Technology:Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3DESY and IBM Develop Big Data Architecture for Science 2DESY and IBM Develop Big Data Architecture for Science 3Consumers Desperate For Measures To Curb Prescription Drug Abuse 2Consumers Desperate For Measures To Curb Prescription Drug Abuse 3
... Fla., Dec. 5, 2011 Hybrid Fuels, Inc., (Pink ... of its main business activities and new strategic goals.  ... a nutraceutical/pharmaceutical business venture that will focus on providing ... normally be treated or addressed with pharmaceutical drugs that ...
... Pharmaceuticals, Inc. (Nasdaq: ANTH ), a biopharmaceutical ... inflammation and autoimmune disorders, today announced Dr. Debra Odink ... Officer and Senior Vice President. "Over ... scientific leadership has been critical to the success of ...
Cached Medicine Technology:Hybrid Fuels, Inc. Announces New Business Strategy 2Anthera Pharmaceuticals Promotes Dr. Debra Odink to Chief Technology Officer 2
(Date:8/22/2014)... 22, 2014 Beat Eczema , ... can use natural methods to completely cure the eczema ... attention of Shane Michaels, prompting an investigative review. ... the skin, it can still be extremely debilitating and ... “The intense itching and pain that it causes on ...
(Date:8/22/2014)... time an oncogenic somatic mutation at amino acid 918 ... identified in small cell lung cancer (SCLC) tumors and ... produced increased intracellular signaling and cell growth. , SCLC ... 15% of all lung cancers and is strongly associated ... has been extensively examined for genomic alterations and targeted ...
(Date:8/22/2014)... Paying tuition and other related educational expenses ... for four nurse educators pursuing advanced degrees, thanks to ... Foundation for Nursing Education . This year’s recipients – ... than in 2013, thanks to these named NLN Foundation ... Marcil Endowment Funds, both donated by Kathy Mershon; the ...
(Date:8/22/2014)... August 22, 2014 Testosterone treatment ... in U.S. courts on behalf of men who ... use of prescription low testosterone therapies, Bernstein Liebhard ... claim was filed against Pfizer Inc. on July ... life-threatening heart issues due to his use of ...
(Date:8/22/2014)... Hudson County, NJ (PRWEB) August 22, 2014 ... that a leading specialist in Internal Medicine, Geriatrics, ... joined the network, CarePoint Health Medical Group. Their ... of highly skilled and experienced physicians comprise CarePoint ... doctors and practices in Hudson County, representing a ...
Breaking Medicine News(10 mins):Health News:Beat Eczema: Review Exposes Susan Clark’s Guide to Curing Eczema Naturally 2Health News:Novel oncogenic RET mutation found in small cell lung cancer 2Health News:NLN Foundation for Nursing Education Announces 2014 Faculty Scholarship Awards 2Health News:NLN Foundation for Nursing Education Announces 2014 Faculty Scholarship Awards 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 4Health News:Dr. Reisner Joins CarePoint Health Medical Group 2
... to Assure ... POWELL, Ohio, June 2 Click4Care, Inc., a ... payers,providers and patients, today announced that Cariten Healthcare, one ... subsidiary of,Covenant Health, has selected ThinkHealth for its medical ...
... Awarded Seven Gold Healthcare Advertising Marketing Awards, ... record number of over 4,400,entries, the 25th ... awards to Publicis Indianapolis and St. Vincent ... television), and marketing,work. Additionally, both entities won ...
... In a multi-site study, Oregon Health & Science University ... also known as MDX-010, works to stimulate the body,s own ... to be effective in study participants with a serious type ... and was resistant to hormonal treatment and, in some cases, ...
... (BioMedical Enterprises, Inc.),a privately held medical device company and ... launch of the OSSAnchor(TM),Grip, a nitinol implant designed to ... the first in the family of OSSAnchor(TM) nitinol soft,tissue ... Grip is a,nitinol implant with aggressive barbs on the ...
... Care Association Raising Profile of Key Issue Impacting,Texas Seniors, ... June 2 With just more than,five months until ... by Baselice Associates finds 57% of voters less likely ... she opposed increasing the amount,the state pays nursing homes ...
... Entitled, ,Ingenuity at Work, Discusses Abbott,s, Contributions to ... ABBOTT PARK, Ill., June 2 Abbott (NYSE: ... Report, "Ingenuity at Work,",which is available online at ... access to care, innovation, science,education and the environment., ...
Cached Medicine News:Health News:Click4Care Signs Award-Winning 500,000-Member Health Plan 2Health News:Publicis Indianapolis and St. Vincent Hospital Win the Gold 2Health News:OHSU Cancer Institute finds that drug stimulated immune system in prostate cancer 2Health News:OHSU Cancer Institute finds that drug stimulated immune system in prostate cancer 3Health News:BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the OSSAnchor(TM) Grip Nitinol Soft Tissue Anchor 2Health News:Texas Eldercare Poll: 57 Percent Less Likely to Back Local Legislator if They Oppose Medicaid Rate Boost 2Health News:Texas Eldercare Poll: 57 Percent Less Likely to Back Local Legislator if They Oppose Medicaid Rate Boost 3Health News:Abbott Releases 2007 Global Citizenship Report Highlighting Strong Commitment to Access to Health Care 2Health News:Abbott Releases 2007 Global Citizenship Report Highlighting Strong Commitment to Access to Health Care 3
The rectangular large-field lens of the 2631 are ideal for reading and writing....
The Multi-Purpose Stand Magnifier is the most versatile stand magnifier. The stand has multiple configurations allowing for all situations where hands-free magnification is needed....
Thinprofile design eyelid implants....
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
Medicine Products: